ResMed Inc.

NYSE:RMD

Medical - Devices

Healthcare
$242.61 +0.85%

+$1.58 today

Market cap
$34.12B
Beta
0.78
P/E (TTM)
18.1
EPS (TTM)
$10.37
Dividend yield
1.28%
52W Low $180.27High $293.81

Volume 1.22M

Average 1.32M

RMD Other Investing Activities

Investing cash flows not reported separately.

ResMed Inc.NYSE: RMD

Other Investing Activities · Q4 FY2026 · quarter ended Jun 2026

Other investing activities turns negative

Q4 FY2026 other investing activities was -$12.41M, compared with $40.41M a year earlier. Trailing-twelve-month other investing activities was -$4.7M.

Context

  • Other investing activities amounted to 0.2% of revenue in FY2026, down 0.5 pp from a year earlier.
  • Other investing activities increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly other investing activities holds near -$12.41M or moves back toward the trailing-twelve-month quarterly average of -$1.17M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$12.41M-160.1% QoQ
Last fiscal yearJun 2026
-$12.41M-135.0% YoY
LTMJun 2026
-$4.7M-110.6% YoY
Other Investing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-130.7%——
1 year-135.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Investing Activities history

USD · from the cash flow

Latest · FY2026
(12.41M) USD
Year-over-year change
-135.0%

Other Investing Activities vs competitors

How RMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so other investing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -110.6% is the lowest of 8, against a peer median of +100.0%.
  • Other investing activities amounts to 0.1% of revenue for RMD, versus a peer median of 0.8%.
RMD Competitors
Other Investing Activities for RMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$2.3B USD+1017.5%+148.9%11.4%
PHGKoninklijke Philips N.V.LTM Jun 2026€197M EUR+2196.8%+232.8%1.1%
MDTMedtronic plcLTM Jul 2026$148M USD+141.5%—0.4%
TFXTeleflex IncorporatedLTM Jun 2026$56.7M USD+54.7%+50.7%2.2%
BSXBoston Scientific CorporationLTM Jun 2026$19M USD-88.4%—0.1%
RMDResMed Inc.LTM Jun 2026$4.7M USD-110.6%—0.1%
ELMDElectromed, Inc.LTM Mar 2026$923K USD——1.3%
ISRGIntuitive Surgical, Inc.LTM Sep 2026$0 USD+100.0%—0.0%
INSPInspire Medical Systems, Inc.LTM Jun 2026$0 USD+100.0%—0.0%
Peer median (excluding RMD) —+100.0%+148.9%0.8%

Competitors are the stored peer set for RMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Net Income779.44M897.56M1.02B1.4B1.52B
Depreciation & Amortization193.84M197.56M216.21M235.81M244.15M
Deferred Income Tax0216K000
Stock-Based Compensation65.26M71.14M80.18M91.66M104.35M
Change in Working Capital(708.08M)(462.13M)44.78M16.74M(74.24M)
Accounts Receivables19.35M(106.51M)(134.28M)(76.68M)(96.78M)
Inventory(311.68M)(248.83M)172.2M(80.17M)(9.92M)
Accounts Payables(247.63M)31.34M090.96M172.72M
Other Working Capital(168.11M)(138.13M)6.86M82.63M(140.26M)
Other Non-Cash Items20.69M(11.05M)39.13M6.66M8.28M
Operating Cash Flow351.15M693.3M1.4B1.75B1.81B
Capital Expenditures(156.04M)(134M)(114.86M)(89.87M)(156.29M)
Acquisitions (Net)(42.78M)(1.01B)(133.46M)(139.25M)(350.72M)
Purchases of Investments(20.72M)(32.23M)(22.46M)(6.42M)(28.54M)
Sales of Investments6.8M3.94M1M02.75M
Other Investing Activities(17.18M)15.2M(15.4M)35.48M(12.41M)
Investing Cash Flow(229.92M)(1.16B)(269.78M)(200.05M)(545.2M)
Debt Repayment122M665M(730M)(40M)(10M)
Common Stock Issued47.38M49.14M53.09M74.44M74.5M
Common Stock Repurchased00(150.01M)(300.03M)(700.04M)
Dividends Paid(245.34M)(258.28M)(282.32M)(310.88M)(349.66M)
Other Financing Activities(52.41M)(32.99M)(10.05M)(29.79M)(21.83M)
Financing Cash Flow(128.36M)422.87M(1.12B)(606.25M)(1.01B)
Effect of Forex Changes(14.43M)(2.15M)(1.72M)25.8M6.18M
Net Change in Cash(21.57M)(45.82M)10.47M971.09M259.78M
Free Cash Flow195.11M559.3M1.29B1.66B1.65B

ResMed Inc.

NYSE:RMD

Intrinsic Alpha fair value

Locked

Current Price

$242.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.